Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical Trial
Clinical trial NCT06043388 · UNKNOWN
Trial details
- NCT number
- NCT06043388
- Sponsor
- Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2023-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.